Ally Bridge Group as of June 30, 2022
Portfolio Holdings for Ally Bridge Group
Ally Bridge Group holds 22 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Argenx Se Sponsored Adr (ARGX) | 13.6 | $15M | 39k | 378.89 | |
| Medavail Holdings Ord | 8.2 | $9.0M | 5.9M | 1.53 | |
| Cogent Biosciences (COGT) | 7.0 | $7.7M | 857k | 9.02 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 6.9 | $7.6M | 115k | 66.03 | |
| Guardant Health (GH) | 5.9 | $6.5M | 160k | 40.34 | |
| Iveric Bio | 5.7 | $6.3M | 650k | 9.62 | |
| Gossamer Bio (GOSS) | 5.3 | $5.9M | 700k | 8.37 | |
| Miragen Therapeutics (VRDN) | 5.2 | $5.7M | 496k | 11.57 | |
| Fate Therapeutics (FATE) | 4.1 | $4.5M | 182k | 24.78 | |
| Cerevel Therapeutics Hldng I (CERE) | 4.1 | $4.5M | 170k | 26.44 | |
| Chinook Therapeutics | 4.0 | $4.4M | 250k | 17.49 | |
| Nuvation Bio Com Cl A (NUVB) | 3.4 | $3.7M | 1.1M | 3.24 | |
| Isoplexis Corp | 3.2 | $3.6M | 1.7M | 2.16 | |
| Somalogic Class A Com | 3.0 | $3.3M | 735k | 4.52 | |
| Syros Pharmaceuticals | 3.0 | $3.2M | 3.4M | 0.96 | |
| Dice Therapeutics | 2.9 | $3.2M | 207k | 15.52 | |
| Relmada Therapeutics (RLMD) | 2.8 | $3.0M | 160k | 18.99 | |
| Rapid Micro Biosystems Class A Com (RPID) | 2.7 | $3.0M | 700k | 4.30 | |
| Nautilus Biotechnology (NAUT) | 2.6 | $2.9M | 1.1M | 2.69 | |
| Science 37 Holdings | 2.6 | $2.8M | 1.4M | 2.01 | |
| Stoke Therapeutics (STOK) | 2.1 | $2.3M | 175k | 13.21 | |
| Jounce Therapeutics | 1.5 | $1.7M | 550k | 3.03 |
